TG Therapeutics
TGTX · NASDAQ
Bulios Fair Price
$46.7
18.3% downside
Current Price
$57.16
According to Bulios Fair Price, TGTX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
TG Therapeutics, Inc. (TGTX) is a biotechnology company specializing in the development of therapeutic products in the fields of oncology and autoimmune diseases. The company focuses on discovering and developing innovative treatment approaches that could improve the quality of life for patients suffering from these diseases. TG Therapeutics, Inc. (TGTX) shares may be suitable for investors seeking opportunities in the biotechnology sector and keeping an eye on advancements in the treatment of oncological and autoimmune diseases.
Sector
Healthcare
Industry
Biotechnology
CEO
Michael S. Weiss
Employees
399
Headquarters
Morrisville
Upcoming events
Earnings
Upcoming earnings report